Similarly, studies by Tang et al. [55] identified that human hepatic stellate cells upregulated OCTN1 following administration of dimethylnitrosamine (DMN), a hepatotoxin that increased levels of both oxidative damage and α-smooth muscle actin, the latter being a marker for activated stellate cells and liver fibrosis. This evidence concerns the gene SLC22A4 and Hepatic fibrosis.